Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MK-1220 is a novel Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 727,500 |
50 mg | 約10-14 週間 | ¥ 959,500 |
100 mg | 約10-14 週間 | ¥ 1,331,500 |
説明 | MK-1220 is a novel Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure. |
分子量 | 779.94 |
分子式 | C40H53N5O9S |
CAS No. | 924270-31-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MK-1220 924270-31-5 Others MK 1220 MK1220 Inhibitor inhibitor inhibit